X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.
暂无分享,去创建一个
A. Fischer | E. Cirillo | A. Plebani | C. Pignata | H. Kanegane | S. Choo | Joanne M. Smart | A. Gennery | E. Haddad | M. Cavazzana‐Calvo | P. Veys | N. Mahlaoui | S. Latour | I. Meyts | H. Chapel | S. Blanche | C. Peters | A. Lankester | D. Moshous | J. Jazbec | N. Kapoor | C. Booth | M. Cowan | B. Strahm | J. P. Schmid | M. Slatter | N. Rieber | S. Bonanomi | A. Soresina | M. Albert | S. Pašić | A. Finocchi | O. Smith | G. Notheis | K. Kałwak | Hilary Kerrigan | H. Ritterbusch | G. Saint-Basile | A. O'meara | P. Sedláček | Kim E. Nichols | Peter D. Arkwright | Colin G. Steward | I. Hanson | Kimberly Gilmour | Paul T Heath | Nico G Hartwig | H. B. Gaspar | I. C. Hanson | Kimberly C. Gilmour | Kim E Nichols | P. D. Arkwright | S. Pasic | Paul T. Heath | Nico G. Hartwig
[1] S. Perrotta,et al. Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up. , 2011, Blood.
[2] H. Koo,et al. The outcome of hematopoietic stem cell transplantation in Korean children with hemophagocytic lymphohistiocytosis , 2010, Pediatric transplantation.
[3] E. Hauben,et al. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. , 2010, Blood.
[4] T. Hara,et al. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis in Japan , 2010, Pediatric blood & cancer.
[5] M. Rimbert,et al. An atypical case of X-linked lymphoproliferative disease revealed as a late cerebral lymphoma , 2010, Journal of Neuroimmunology.
[6] S. Pittaluga,et al. Lymphocytic vasculitis involving the central nervous system occurs in patients with X‐linked lymphoproliferative disease in the absence of Epstein–Barr virus infection , 2009, Pediatric blood & cancer.
[7] H. Hasle,et al. Treatment of the X‐linked lymphoproliferative, Griscelli and Chédiak–Higashi syndromes by HLH directed therapy , 2009, Pediatric blood & cancer.
[8] Steven R. Martin,et al. Chronic Active Gastritis in X-linked Lymphoproliferative Disease , 2008, The American journal of surgical pathology.
[9] M. Aricò,et al. HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis , 2007, Pediatric blood & cancer.
[10] P. Veys,et al. Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis. , 2006, Blood.
[11] S. Pittaluga,et al. Selective generation of functional somatically mutated IgM+CD27+, but not Ig isotype-switched, memory B cells in X-linked lymphoproliferative disease. , 2006, The Journal of clinical investigation.
[12] R. Egeler,et al. Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature , 2005, Bone Marrow Transplantation.
[13] R. Clementi,et al. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells. , 2005, Blood.
[14] S. Tangye,et al. Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells. , 2005, The Journal of clinical investigation.
[15] S. Tangye,et al. Regulation of NKT cell development by SAP, the protein defective in XLP , 2005, Nature Medicine.
[16] S. Tangye,et al. Molecular and cellular pathogenesis of X‐linked lymphoproliferative disease , 2005, Immunological reviews.
[17] H. Kanegane,et al. X‐linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitis , 2005, American journal of hematology.
[18] J. Neglia,et al. Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non‐malignant diseases , 2004, British journal of haematology.
[19] U. Sack,et al. Persistent Hypogammaglobulinemia Following Mononucleosis in Boys Is Highly Suggestive of X-Linked Lymphoproliferative Disease—Report of Three Cases , 2004, Journal of Clinical Immunology.
[20] H. Chapel,et al. Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency , 2004, Clinical and experimental immunology.
[21] A. Thrasher,et al. SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease. , 2004, Blood.
[22] K. Gilmour,et al. X‐Linked lymphoproliferative disease: three atypical cases , 2001, Clinical and experimental immunology.
[23] R. Biassoni,et al. Analysis of the molecular mechanism involved in 2B4‐mediated NK cell activation: evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells , 2000, European journal of immunology.
[24] M. Colonna,et al. Patients with X‐linked lymphoproliferative disease have a defect in 2B4 receptor‐mediated NK cell cytotoxicity , 2000, European journal of immunology.
[25] G. Klein,et al. Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. , 2000, Blood.
[26] H. Pabst,et al. Cutting Edge: Defective NK Cell Activation in X-Linked Lymphoproliferative Disease1 , 2000, The Journal of Immunology.
[27] S. Tangye,et al. Cutting Edge: Functional Requirement for SAP in 2B4-Mediated Activation of Human Natural Killer Cells as Revealed by the X-Linked Lymphoproliferative Syndrome1 , 2000, The Journal of Immunology.
[28] P. Veys,et al. Non-myeloablative stem cell transplantation for congenital immunodeficiencies. , 2000, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[29] K. Nichols,et al. Diagnosis of X‐linked lymphoproliferative disease by analysis of SLAM‐associated protein expression , 2000, European journal of immunology.
[30] Meindl,et al. Recurrent B‐cell non‐Hodgkin's lymphoma in two brothers with X‐linked lymphoproliferative disease without evidence for Epstein–Barr virus infection , 2000, British journal of haematology.
[31] Wan Ariffin Bin Abdullah,et al. Med Pediatr Oncol , 1999 .
[32] E. Snyder,et al. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[33] Jack R. Davis,et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene , 1998, Nature Genetics.
[34] D. Allen,et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM , 1998, Nature.
[35] P. Arkwright,et al. X linked lymphoproliferative disease in a United Kingdom family , 1998, Archives of disease in childhood.
[36] R. Egeler,et al. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. , 1997, Medical and pediatric oncology.
[37] M. Okano,et al. Epstein‐Barr virus‐associated hemophagocytic syndrome and fatal infectious mononucleosis , 1996, American journal of hematology.
[38] Jack R. Davis,et al. X-Linked Lymphoproliferative Disease: Twenty-Five Years after the Discovery , 1995, Pediatric Research.
[39] D. Purtilo,et al. Methods of detection of new families with X-linked lymphoproliferative disease. , 1991, Cancer genetics and cytogenetics.
[40] G. Thiele,et al. Immunovirological studies of fatal infectious mononucleosis in a patient with X-linked lymphoproliferative syndrome treated with intravenous immunoglobulin and interferon-alpha. , 1990, Clinical immunology and immunopathology.
[41] D. Weisenburger,et al. Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. , 1987, Archives of pathology & laboratory medicine.
[42] H. Ochs,et al. Necrotizing lymphoid vasculitis in X-linked lymphoproliferative syndrome. , 1985, Archives of pathology & laboratory medicine.
[43] G. Vawter,et al. X-LINKED RECESSIVE PROGRESSIVE COMBINED VARIABLE IMMUNODEFICIENCY (DUNCAN'S DISEASE) , 1975, The Lancet.
[44] B. Bower,et al. WATER INTOXICATION AND MIST-TENT THERAPY , 1974 .
[45] C. Terhorst,et al. Signaling lymphocytic activation molecule-associated protein controls NKT cell functions. , 2005, Journal of immunology.